Human Gene IGF1 (uc001tjp.4)
  Description: Homo sapiens insulin-like growth factor 1 (somatomedin C) (IGF1), transcript variant 3, mRNA.
RefSeq Summary (NM_001111285): The protein encoded by this gene is similar to insulin in function and structure and is a member of a family of proteins involved in mediating growth and development. The encoded protein is processed from a precursor, bound by a specific receptor, and secreted. Defects in this gene are a cause of insulin-like growth factor I deficiency. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar processing to generate mature protein. [provided by RefSeq, Sep 2015].
Transcript (Including UTRs)
   Position: hg19 chr12:102,811,454-102,874,378 Size: 62,925 Total Exon Count: 4 Strand: -
Coding Region
   Position: hg19 chr12:102,811,596-102,874,159 Size: 62,564 Coding Exon Count: 4 

Page IndexSequence and LinksUniProtKB CommentsPrimersGenetic AssociationsMalaCards
CTDGene AllelesRNA-Seq ExpressionMicroarray ExpressionRNA StructureProtein Structure
Other SpeciesGO AnnotationsmRNA DescriptionsPathwaysOther NamesModel Information
Methods
Data last updated at UCSC: 2013-06-14

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr12:102,811,454-102,874,378)mRNA (may differ from genome)Protein (195 aa)
Gene SorterGenome BrowserOther Species FASTAVisiGeneGene interactionsTable Schema
AlphaFoldBioGPSEnsemblEntrez GeneExonPrimerGeneCards
HGNCLynxMalacardsMGIneXtProtOMIM
PubMedReactomeTreefamUniProtKBWikipediaBioGrid CRISPR DB

-  Comments and Description Text from UniProtKB
  ID: IGF1_HUMAN
DESCRIPTION: RecName: Full=Insulin-like growth factor I; Short=IGF-I; AltName: Full=Mechano growth factor; Short=MGF; AltName: Full=Somatomedin-C; Flags: Precursor;
FUNCTION: The insulin-like growth factors, isolated from plasma, are structurally and functionally related to insulin but have a much higher growth-promoting activity. May be a physiological regulator of [1-14C]-2-deoxy-D-glucose (2DG) transport and glycogen synthesis in osteoblasts. Stimulates glucose transport in rat bone-derived osteoblastic (PyMS) cells and is effective at much lower concentrations than insulin, not only regarding glycogen and DNA synthesis but also with regard to enhancing glucose uptake.
SUBCELLULAR LOCATION: Secreted.
DISEASE: Defects in IGF1 are the cause of insulin-like growth factor I deficiency (IGF1 deficiency) [MIM:608747]. IGF1 deficiency is an autosomal recessive disorder characterized by growth retardation, sensorineural deafness and mental retardation.
SIMILARITY: Belongs to the insulin family.
SEQUENCE CAUTION: Sequence=CAA27250.1; Type=Erroneous gene model prediction;
WEB RESOURCE: Name=SHMPD; Note=The Singapore human mutation and polymorphism database; URL="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&genename=HLA-DQB1";
WEB RESOURCE: Name=NIEHS-SNPs; URL="http://egp.gs.washington.edu/data/igf1/";
WEB RESOURCE: Name=Wikipedia; Note=Insulin-like growth factor 1 entry; URL="http://en.wikipedia.org/wiki/Insulin-like_growth_factor_1";

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  Genetic Association Studies of Complex Diseases and Disorders
  Genetic Association Database (archive): IGF1
CDC HuGE Published Literature: IGF1
Positive Disease Associations: , Birth Weight , body height , bone density fractures, vertebral , bone mineral density , breast cancer , breast cancer; insulin-like growth factor , Breast density , colorectal cancer , diabetes, type 2 , diabetes, type 2; cardiovascular disease; birth weight , diabetes, type 2; myocardial infarction , fasting glucose-related traits , fasting insulin-related traits , Fibromyoma , Glucose Transporter Type 2 , height , IGF-I , IGF-I levels; IGFBP-3 levels , Insulin Resistance , insulin-like growth factor-1; estrogen metabolism , insulin-like growth factor-1; Insulin-like growth factor-3 , Laron-type dwarfism , lymphocyte subset counts in neonates , mamographic density , microalbuminuria , myocardial infarct, mortality in , Natural Menopause|Obesity|POF - Premature ovarian failure|POLYCYSTIC OVARIAN SYNDROME|Polycystic Ovary Syndrome|Primary Ovarian Insufficiency|Puberty, Delayed|Puberty, Precocious|Thrombophilia|Tobacco Use Disorder , osteoporosis; cirrhosis, primary biliary , postnatal growth , primary biliary cirrhosis] , prostate cancer , prostatic hyperplasia; prostate cancer , retinopathy, diabetic , small for gestational age , subarachnoid hemorrhage , triglycerides , weight gain
Related Studies:

  1. Cathrine Hoyo , et al. Journal of the National Medical Association 2009 101(7):711-6, Predictors of variation in serum IGF1 and IGFBP3 levels in healthy African American and white men., Journal of the National Medical Association 2009 101(7):711-6. [PubMed 19634593]
    If successfully replicated in larger studies, these findings would add to recent evidence, suggesting known genetic and lifestyle chronic disease risk factors influence IGF1 and IGFBP3 circulating levels differently in African Americans and whites.
  2. Birth Weight
    Vera A A van Houten , et al. European journal of endocrinology 2008 159(3):209-16, A variant of the IGF-I gene is associated with blood pressure but not with left heart dimensions at the age of 2 years: the Generation R Study., European journal of endocrinology 2008 159(3):209-16. [PubMed 18544576]
  3. body height
    Rietveld, I. et al. 2004, A polymorphic CA repeat in the IGF-I gene is associated with gender-specific differences in body height, but has no effect on the secular trend in body height., Clinical endocrinology. 2004 Aug;61(2):195-203. [PubMed 15272914]
    In conclusion, we observed an optimum in IGF-I levels and final body height for the 192-bp and 194-bp allele of the IGF-I gene. A gender-specific effect of the IGF-I alleles on body height was observed. The secular trend in body height observed in our elderly Dutch population was similar for the different genotypes; carriers of the 192-bp and/or the 194-bp allele remained significantly taller throughout time.
           more ... click here to view the complete list

-  MalaCards Disease Associations
  MalaCards Gene Search: IGF1
Diseases sorted by gene-association score: growth retardation with deafness and mental retardation due to igf1 deficiency* (1369), insulin-like growth factor i* (338), pituitary gland disease (36), uterine fibroid (28), diffuse idiopathic skeletal hyperostosis (23), leprechaunism (23), osteochondrosis (22), laron dwarfism (21), hyperpituitarism (20), muscle hypertrophy (20), craniopharyngioma (17), acromegaly (17), acid-labile subunit, deficiency of (17), anorexia nervosa (15), hypopituitarism (15), rabson-mendenhall syndrome (15), protein-energy malnutrition (15), pineal region choriocarcinoma (14), slipped capital femoral epiphysis (13), hyperinsulinism (13), hyperprolactinemia (13), pituitary adenoma (13), secondary adrenal insufficiency (12), polycystic ovary syndrome (12), turner syndrome (12), anovulation (12), osteoporosis (12), keratopathy (11), pituitary adenoma, growth hormone-secreting (11), diabetes mellitus, insulin-dependent (11), sheehan syndrome (11), glucose intolerance (11), microvascular complications of diabetes 1 (11), gonadal disease (10), growth hormone deficiency (10), hyperandrogenism (10), cerebral hypoxia (10), mixed cell adenoma (10), acidophil adenoma (10), pituitary tumors (10), malignant pineal area germ cell neoplasm (10), malignant ovarian cyst (9), prader-willi syndrome (9), spondyloepiphyseal dysplasia tarda (9), neuroaxonal dystrophy (9), pituitary hormone deficiency, combined, 2 (9), postpoliomyelitis syndrome (9), central precocious puberty (8), fibrous dysplasia (8), pallister-hall syndrome (8), peho syndrome (8), endocrine pancreas disease (8), isolated growth hormone deficiency (8), central nervous system organ benign neoplasm (8), ovarian disease (8), hyperglycemia (8), short bowel syndrome (7), thalassemia major (7), growth hormone deficiency, isolated, type ii (7), breast disease (7), glucocorticoid-induced osteoporosis (7), fetal macrosomia (7), sleep apnea (7), hormone producing pituitary cancer (6), idiopathic central precocious puberty (6), prostate cancer (6), pituitary adenoma, prolactin-secreting (6), growth hormone deficiency, isolated, type ib (6), fasting hypoglycemia (6), idiopathic juvenile osteoporosis (6), asbestos-related lung carcinoma (6), obstructive sleep apnea (6), microvascular complications of diabetes 5 (6), silver-russell syndrome (6), robinow syndrome (6), carcinoid syndrome (6), endometrial cancer (6), colorectal adenoma (6), exudative vitreoretinopathy 1 (6), hyperostosis (6), organ system benign neoplasm (5), chronic fatigue syndrome (5), pancreas disease (5), pellagra (5), hypothyroidism, congenital, nongoitrous 4 (5), acquired metabolic disease (5), endocrine organ benign neoplasm (5), glucose metabolism disease (5), sarcocystosis (5), acromesomelic dysplasia, maroteaux type (5), abetalipoproteinemia (5), mccune-albright syndrome, somatic, mosaic (5), traumatic brain injury (5), noonan syndrome 1 (5), sebaceous gland disease (5), opiate dependence (5), male reproductive organ cancer (5), meninges hemangiopericytoma (5), bone resorption disease (4), adenoma (4), pseudopapilledema (4), mutagen sensitivity (4), cell type benign neoplasm (4), rubeosis iridis (4), brain injury (4), persistent fetal circulation syndrome (4), breast cancer (4), hallermann-streiff syndrome (4), osteogenesis imperfecta, type i (4), diabetes mellitus, noninsulin-dependent (3), obesity (3), eye disease (3), motor neuron disease (2), osteosarcoma, somatic (2), chronic kidney failure (2), multiple myeloma (2), colorectal cancer (2), ewing sarcoma (2), hydrocephalus (2), bone remodeling disease (2), thyroid gland disease (2), overnutrition (1), amyotrophic lateral sclerosis 1 (1), dilated cardiomyopathy (1), retinal vascular disease (1), diamond-blackfan anemia (1), reproductive organ cancer (1)
* = Manually curated disease association

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene           more ... click here to view the complete list

+  Common Gene Haplotype Alleles
  Press "+" in the title bar above to open this section.

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 14.29 RPKM in Cervix - Endocervix
Total median expression: 171.82 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -39.60219-0.181 Picture PostScript Text
3' UTR -11.89142-0.084 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Protein Domain and Structure Information
  InterPro Domains: Graphical view of domain structure
IPR022341 - IGF-I
IPR016179 - Insulin-like
IPR022350 - Insulin-like_growth_factor
IPR022353 - Insulin_CS
IPR022352 - Insulin_family

Pfam Domains:
PF00049 - Insulin/IGF/Relaxin family

SCOP Domains:
56994 - Insulin-like

Protein Data Bank (PDB) 3-D Structure
MuPIT help
1B9G - NMR 1BQT - NMR MuPIT 1GF1 - Model 1GZR - X-ray MuPIT 1GZY - X-ray MuPIT 1GZZ - X-ray MuPIT 1H02 - X-ray MuPIT 1H59 - X-ray 1IMX - X-ray MuPIT 1PMX - NMR MuPIT 1TGR - X-ray MuPIT 1WQJ - X-ray MuPIT 2DSP - X-ray MuPIT 2DSQ - X-ray MuPIT 2DSR - X-ray MuPIT 2GF1 - NMR MuPIT 3GF1 - NMR MuPIT 3LRI - NMR MuPIT


ModBase Predicted Comparative 3D Structure on P05019
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologNo orthologNo ortholog
Gene Details     
Gene Sorter     
      
      
      

-  Gene Ontology (GO) Annotations with Structured Vocabulary
  Molecular Function:
GO:0005158 insulin receptor binding
GO:0005159 insulin-like growth factor receptor binding
GO:0005178 integrin binding
GO:0005179 hormone activity
GO:0005515 protein binding
GO:0008083 growth factor activity

Biological Process:
GO:0000187 activation of MAPK activity
GO:0001501 skeletal system development
GO:0001775 cell activation
GO:0002576 platelet degranulation
GO:0007165 signal transduction
GO:0007265 Ras protein signal transduction
GO:0007517 muscle organ development
GO:0008283 cell proliferation
GO:0008284 positive regulation of cell proliferation
GO:0009408 response to heat
GO:0009441 glycolate metabolic process
GO:0010468 regulation of gene expression
GO:0010469 regulation of receptor activity
GO:0010560 positive regulation of glycoprotein biosynthetic process
GO:0010613 positive regulation of cardiac muscle hypertrophy
GO:0010628 positive regulation of gene expression
GO:0014065 phosphatidylinositol 3-kinase signaling
GO:0014068 positive regulation of phosphatidylinositol 3-kinase signaling
GO:0014834 skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration
GO:0014896 muscle hypertrophy
GO:0014904 myotube cell development
GO:0014911 positive regulation of smooth muscle cell migration
GO:0030166 proteoglycan biosynthetic process
GO:0030335 positive regulation of cell migration
GO:0032148 activation of protein kinase B activity
GO:0033160 positive regulation of protein import into nucleus, translocation
GO:0034392 negative regulation of smooth muscle cell apoptotic process
GO:0035630 bone mineralization involved in bone maturation
GO:0040014 regulation of multicellular organism growth
GO:0042104 positive regulation of activated T cell proliferation
GO:0042531 positive regulation of tyrosine phosphorylation of STAT protein
GO:0043066 negative regulation of apoptotic process
GO:0043388 positive regulation of DNA binding
GO:0043410 positive regulation of MAPK cascade
GO:0043491 protein kinase B signaling
GO:0043568 positive regulation of insulin-like growth factor receptor signaling pathway
GO:0044267 cellular protein metabolic process
GO:0045445 myoblast differentiation
GO:0045669 positive regulation of osteoblast differentiation
GO:0045725 positive regulation of glycogen biosynthetic process
GO:0045821 positive regulation of glycolytic process
GO:0045840 positive regulation of mitotic nuclear division
GO:0045893 positive regulation of transcription, DNA-templated
GO:0045944 positive regulation of transcription from RNA polymerase II promoter
GO:0046326 positive regulation of glucose import
GO:0046579 positive regulation of Ras protein signal transduction
GO:0048009 insulin-like growth factor receptor signaling pathway
GO:0048015 phosphatidylinositol-mediated signaling
GO:0048146 positive regulation of fibroblast proliferation
GO:0048661 positive regulation of smooth muscle cell proliferation
GO:0050679 positive regulation of epithelial cell proliferation
GO:0050714 positive regulation of protein secretion
GO:0050731 positive regulation of peptidyl-tyrosine phosphorylation
GO:0050821 protein stabilization
GO:0051450 myoblast proliferation
GO:0060283 negative regulation of oocyte development
GO:0061051 positive regulation of cell growth involved in cardiac muscle cell development
GO:0070371 ERK1 and ERK2 cascade
GO:0070886 positive regulation of calcineurin-NFAT signaling cascade
GO:0090201 negative regulation of release of cytochrome c from mitochondria
GO:1904075 positive regulation of trophectodermal cell proliferation
GO:1904646 cellular response to beta-amyloid
GO:1904707 positive regulation of vascular smooth muscle cell proliferation
GO:1905460 negative regulation of vascular associated smooth muscle cell apoptotic process
GO:2000679 positive regulation of transcription regulatory region DNA binding
GO:2001237 negative regulation of extrinsic apoptotic signaling pathway

Cellular Component:
GO:0005576 extracellular region
GO:0005615 extracellular space
GO:0016942 insulin-like growth factor binding protein complex
GO:0031093 platelet alpha granule lumen
GO:0035867 alphav-beta3 integrin-IGF-1-IGF1R complex
GO:0042567 insulin-like growth factor ternary complex
GO:0070382 exocytic vesicle


-  Descriptions from all associated GenBank mRNAs
  X57025 - Human IGF-I mRNA for insulin-like growth factor I.
AB209184 - Homo sapiens mRNA for insulin-like growth factor 1 (somatomedin C); insulin-like growth factor 1 (somatomedia C) variant protein.
BC152321 - Homo sapiens insulin-like growth factor 1 (somatomedin C), mRNA (cDNA clone MGC:157712 IMAGE:40129266), complete cds.
M27544 - Human insulin-like growth factor mRNA, complete cds.
M29644 - Human insulin-like growth factor I mRNA, complete cds.
X00173 - Homo sapiens mRNA for insulin-like growth factor 1A precursor, complete CDS.
X56773 - H.sapiens mRNA for IGF-1a.
M37484 - Human insulin-like growth factor I (IGF-I) mRNA, complete cds.
BC160082 - Synthetic construct Homo sapiens clone IMAGE:100064018, MGC:193197 insulin-like growth factor 1 (somatomedin C) (IGF1) mRNA, encodes complete protein.
CR541861 - Homo sapiens full open reading frame cDNA clone RZPDo834H0732D for gene IGF1, insulin-like growth factor 1 (somatomedin C); complete cds, incl. stopcodon.
AK312231 - Homo sapiens cDNA, FLJ92522, Homo sapiens insulin-like growth factor 1 (somatomedin C) (IGF1),mRNA.
AB384874 - Synthetic construct DNA, clone: pF1KB3912, Homo sapiens IGF1 gene for insulin-like growth factor IA precursor, complete cds, without stop codon, in Flexi system.
U40870 - Human alternatively spliced human insulin-like growth factor-I (IGF-I) mRNA, partial cds.
E01349 - cDNA encoding ppIGF-1B.
M11568 - Human insulin-like growth factor IB (IGF-IB) cDNA to mRNA.
X56774 - H.sapiens mRNA for IGF-1b.
BC148266 - Homo sapiens IGF1 protein (IGF1) mRNA, partial cds.
JD418891 - Sequence 399915 from Patent EP1572962.
JD252763 - Sequence 233787 from Patent EP1572962.
JD503220 - Sequence 484244 from Patent EP1572962.

-  Biochemical and Signaling Pathways
  KEGG - Kyoto Encyclopedia of Genes and Genomes
hsa04114 - Oocyte meiosis
hsa04115 - p53 signaling pathway
hsa04150 - mTOR signaling pathway
hsa04510 - Focal adhesion
hsa04730 - Long-term depression
hsa04914 - Progesterone-mediated oocyte maturation
hsa04960 - Aldosterone-regulated sodium reabsorption
hsa05200 - Pathways in cancer
hsa05214 - Glioma
hsa05215 - Prostate cancer
hsa05218 - Melanoma
hsa05410 - Hypertrophic cardiomyopathy (HCM)
hsa05414 - Dilated cardiomyopathy

BioCarta from NCI Cancer Genome Anatomy Project
h_badPathway - Regulation of BAD phosphorylation
h_igf1Pathway - IGF-1 Signaling Pathway
h_erythPathway - Erythrocyte Differentiation Pathway
h_ghrelinPathway - Ghrelin: Regulation of Food Intake and Energy Homeostasis
h_hdacPathway - Control of skeletal myogenesis by HDAC & calcium/calmodulin-dependent kinase (CaMK)
h_igf1mtorpathway - Skeletal muscle hypertrophy is regulated via AKT/mTOR pathway
h_nfatPathway - NFAT and Hypertrophy of the heart (Transcription in the broken heart)
h_longevityPathway - The IGF-1 Receptor and Longevity

Reactome (by CSHL, EBI, and GO)

Protein P05019 (Reactome details) participates in the following event(s):

R-HSA-381412 IGFBP2 binds IGF forming IGF:IGFBP2
R-HSA-381487 IGFBP1 binds IGF forming IGF:IGFBP1
R-HSA-381496 Formation of the IGF:IGFBP3:ALS complex
R-HSA-381503 IGFBP6 binds IGF forming IGF:IGFBP6
R-HSA-381543 IGFBP4 binds IGF forming IGF:IGFBP4
R-HSA-381545 Formation of the IGF:IGFBP5:ALS complex
R-HSA-2404200 IGF1,2 binds IGF1R
R-HSA-381435 Matrix metalloproteinase proteolyzes IGF:IGFBP3:ALS
R-HSA-381446 Thrombin proteolyzes IGF:IGFBP3:ALS
R-HSA-381461 Plasmin proteolyzes IGF:IGFBP-3:ALS
R-HSA-381466 Prostate-specific Antigen proteolyzes IGF:IGFBP3:ALS
R-HSA-381500 Cathepsin G proteolyzes IGF:IGFBP3:ALS
R-HSA-381518 PAAP-A proteolyzes IGF:IGFBP4
R-HSA-381537 PAPP-A2 proteolyzes IGF:IGFBP5:ALS
R-HSA-481007 Exocytosis of platelet alpha granule contents
R-HSA-2404199 IGF1,2:IGF1R autophosphorylates
R-HSA-2404195 IGF1,2:p-Y1161,1165,1166-IGF1R binds SHC1
R-HSA-2428922 IGF1,2:p-Y1161,1165,1166-IGF1R binds IRS2
R-HSA-2428930 IGF1,2:p-Y1161,1165,1166-IGF1R binds IRS1,4
R-HSA-5686072 p-3Y-SHC1 dissociates from IGF1R
R-HSA-2404193 IGF1R phosphorylates SHC1
R-HSA-2428926 IGF1,2:p-Y1161,1165,1166-IGF1R phosphorylates IRS1,2,4
R-HSA-381426 Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
R-HSA-2404192 Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
R-HSA-114608 Platelet degranulation
R-HSA-2428933 SHC-related events triggered by IGF1R
R-HSA-2428928 IRS-related events triggered by IGF1R
R-HSA-392499 Metabolism of proteins
R-HSA-9006934 Signaling by Receptor Tyrosine Kinases
R-HSA-76005 Response to elevated platelet cytosolic Ca2+
R-HSA-2428924 IGF1R signaling cascade
R-HSA-162582 Signal Transduction
R-HSA-76002 Platelet activation, signaling and aggregation
R-HSA-109582 Hemostasis

-  Other Names for This Gene
  Alternate Gene Symbols: B2RWM7, IBP1, IGF1_HUMAN, NM_001111285, NP_001104755, P01343, P05019, Q14620
UCSC ID: uc001tjp.4
RefSeq Accession: NM_001111285
Protein: P05019 (aka IGF1_HUMAN)
CCDS: CCDS44962.1

-  Gene Model Information
 
category: coding nonsense-mediated-decay: no RNA accession: NM_001111285.1
exon count: 4CDS single in 3' UTR: no RNA size: 949
ORF size: 588CDS single in intron: no Alignment % ID: 100.00
txCdsPredict score: 1358.00frame shift in genome: no % Coverage: 100.00
has start codon: yes stop codon in genome: no # of Alignments: 1
has end codon: yes retained intron: no # AT/AC introns 0
selenocysteine: no end bleed into intron: 279# strange splices: 0
Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.